BioNeutra Partners With Lehvoss For European Launch Of Canada’s Newest Low Calorie, Natural Sweetener – VITAFIBE(TM) IMO

Tickers: XTSX:BGA
Tags: Bioceuticals

Edmonton, Alberta / TheNewswire / July 4, 2018 – BioNeutra Global Corporation ("BioNeutra" or the "Company") (TSXV: BGA), a functional and health food and beverage ingredient manufacturer producing isomalto-oligosaccharide ("IMO") using its patented processes, is pleased to announce that it has partnered with Gee Lawson, the nutritional division of LEHVOSS UK, to launch VitaFiber(TM) IMO in Europe.

The introduction of VitaFiber(TM) IMO to the European market makes it the only combination low calorie natural sweetener and dietary fibre available on the continent. "It can help with the duel problems of weight gain and digestive health – both growing issues in Europe," says BioNeutra CEO Dr. Jianhua Zhu. The World Health Organization estimates 59% of European adults are overweight or obese just behind Americans whose rate is 61%.

Using its science, studies, clinical research including a Health Canada approved trial and a unique patented process, BioNeutra transforms starch molecules from agricultural crops like non-GMO corn, pea and tapioca into functional healthy molecules of isomalto-oligosaccarides (IMOs) using a natural enzymatic process without any chemical modification.

"With our continued success in the U.S. and other countries throughout the world, we are excited to have LEHVOSS as our distributor to expand our presence into Europe," says Dr. Zhu.

Jonathan Shorts, Head of LifeSciences LEHVOSS UK Ltd/Gee Lawson says, "Adding VitaFiber to our portfolio gives us the opportunity to provide our customers with a product underpinned by science which is a weight management/digestive health solution. We are excited by this partnership which enables us to bring VitaFiber to this important region of the world that demands value, science and quality."

VitaFiber(TM) IMO has been reviewed by the world’s top health regulatory authorities including the EFSA and approved for sale in 36 countries on four continents. It’s used by makers of ice cream, protein bars, yogurt, beverages and confectionaries. Its bulking, binding properties are particularly important to manufacturers searching for ways to make products that health conscious consumers are seeking.

VitaFiber(TM) is now part of the Gee Lawson range of specialty ingredients, distributed in Europe by LEHVOSS.

About BioNeutra

BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on VitaFiber(TM) IMOs.

The Company’s lead product, VitaFiber(TM), is an advanced functional and health food and beverage ingredient scientifically made from natural agricultural products, is generally regarded as safe (GRAS) by the U.S. Food & Drug Administration, and is European Food Safety Authority and Health Canada approved as a novel food ingredient. VitaFiber(TM) is naturally sweet and lower in calories than regular sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health.

The Company produces VitaFiber(TM) using its patented processes that naturally transform starch molecules from agriculture cereal crops including corn, wheat, barley, potato, or tapioca into the functional health molecules of VitaFiber(TM) IMO. The VitaFiber(TM) manufacturing process is based upon a natural enzymatic conversion of starch molecules without any chemical modification involved, making VitaFiber(TM) a natural food and beverage ingredient. VitaFiber(TM) is also non-GMO, vegan-friendly, gluten-free, Kosher and Halal certified and available as certified organic.

The Company’s customers include a mix of small and medium enterprises and a number of high-profile food and beverage manufacturers in Canada, the U.S., Europe, the United Kingdom, and Mexico. VitaFiber(TM) is also available for retail purchase across the globe through Amazon.com and other direct-to-consumer retailers.

Further information about BioNeutra is available on the Company’s website at www.bioneutra.ca and the SEDAR website at www.sedar.com.

About LEHVOSS Nutrition Division – Gee Lawson

Gee Lawson is a UK based division of the Hamburg headquartered LEHVOSS Group, operating with a network of people and offices across Europe. Gee Lawson specializes in the sourcing, technical approval, sales and marketing of specialty ingredients for the Food Supplement, Functional Foods and Animal Feed industries. Dedicated departments within the LEHVOSS Group also service the cosmetic and pharma sectors across the globe with selected minerals also offered by the Mineral Division based in Hamburg. Gee Lawson works with an approved supplier network and global resource to deliver expert knowledge and quality solutions to all our customers.

Teresita Ruda

+39 (0) 345 842 1499

teresita.ruda@lehovss.co.uk

LEHVOSS UK I Gee Lawson 1st Floor, Premier House

309 Ballards Lane, London N1 2 8LY- ENGLAND

+44 (0) 20 8343 5400

For further information on BioNeutra, please contact:

Dr. Jianhua Zhu

President and Chief Executive Officer

Tel: (780) 466-1481 (Ext. 111)

Email: jianhua.zhu@bioneutra.ca

Forward-Looking Information

This press release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of BioNeutra. Forward-looking information is based on certain key expectations and assumptions made by the management of BioNeutra. Although BioNeutra believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because BioNeutra can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. BioNeutra disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.

Copyright (c) 2018 TheNewswire – All rights reserved.

TheNewswire.com – RSS (all)